Australia looks to add local mRNA manufacturing capability
Tom McIlroyCanberra Bureau Chief
The manufacture of future COVID-19 vaccine boosters and annual flu shots could be supported by early-stage plans for domestic production of mRNA vaccines in Australia.
Preliminary discussions and the development of a business case are under way, as the Morrison government faces continued pressure over supply problems related to overseas-produced COVID-19 vaccines.
Loading...
Tom McIlroy is the Financial Review’s Canberra bureau chief based in the press gallery at Parliament House. He was previously the AFR’s political correspondent. Connect with Tom on Twitter. Email Tom at thomas.mcilroy@afr.com
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Federal
Fetching latest articles